longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SHPH

SHPH
3.5401.14%( +0.040 )

LongbridgeAI

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga_article
Jul 31, 2026 at 05:05 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

In Friday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Replimune Group (up 96.1%), SCYNEXIS (up 22.54%), and Shuttle Pharmaceuticals (up 19.74%). Conversely, major losers featured Karyopharm Therapeutics (down 72.5%), Nuwellis (down 63.38%), and Moleculin Biotech (down 62.36%). These movements occurred following the release of Q2 earnings reports for some companies.

Gainers

  • Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular session.
  • SCYNEXIS (NASDAQ:SCYX) stock moved upwards by 22.54% to $4.57. The market value of their outstanding shares is at $37.0 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 19.74% to $3.7. The market value of their outstanding shares is at $1.8 million.
  • CareDx (NASDAQ:CDNA) shares increased by 14.9% to $43.78. The market value of their outstanding shares is at $1.9 billion. As per the press release, Q2 earnings came out yesterday.
  • Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 14.28% to $1.8. The market value of their outstanding shares is at $3.7 million.
  • Zentek (NASDAQ:ZTEK) stock moved upwards by 13.89% to $0.63. The company's market cap stands at $69.8 million.

Losers

  • Karyopharm Therapeutics (NASDAQ:KPTI) stock declined by 72.5% to $1.93 during Friday's regular session. The company's market cap stands at $158.8 million.
  • Nuwellis (NASDAQ:NUWE) stock decreased by 63.38% to $1.63.
  • Moleculin Biotech (NASDAQ:MBRX) stock declined by 62.36% to $0.38. The market value of their outstanding shares is at $5.4 million.
  • Bioage Labs (NASDAQ:BIOA) stock decreased by 61.74% to $9.51. The market value of their outstanding shares is at $1.1 billion.
  • Myriad Genetics (NASDAQ:MYGN) stock decreased by 46.28% to $2.88. The market value of their outstanding shares is at $507.1 million. As per the press release, Q2 earnings came out yesterday.
  • GlucoTrack (NASDAQ:GCTK) stock decreased by 39.56% to $0.47. The market value of their outstanding shares is at $5.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Login to unlock1,268characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Moleculin Biotech

Moleculin Biotech

USMBRX

+5.66%

Nuwellis

Nuwellis

USNUWE

+0.88%

Replimune

Replimune

USREPL

-1.80%